Anacor

Arcutis Biotherapeutics

This biopharmaceutical company develops and commercialises topical treatments for patients with chronic inflammatory skin diseases such as psoriasis, eczema, and seborrhoeic dermatitis.

Viamet Pharmaceuticals

This company develops small molecule antifungal medicines for patients with chronic and life-threatening infections using a proprietary metalloenzyme inhibitor design platform.

NovaBiotics

This biotechnology company develops anti-infective therapies and conditioning treatments for nail, skin, scalp, and hair health for patients and personal care consumers.

Brickell Biotech

This pharmaceutical company develops prescription therapeutics for patients with skin diseases, such as hyperhidrosis, atopic dermatitis, and acne.

Blueberry Therapeutics

This clinical-stage biotechnology company develops nanomedicine therapies for patients with common dermatological and fungal infections using a proprietary delivery platform.

Dermira

This biopharmaceutical company develops and commercialises medical dermatology treatments for patients with chronic skin conditions such as excessive sweating and atopic dermatitis.

Acurx Pharmaceuticals

This biopharmaceutical company develops small molecule antibiotics to treat patients with bacterial infections caused by priority pathogens.

Akanocure Pharmaceuticals

This company develops small molecule drugs targeting orphan and unmet needs in oncology for healthcare providers and patients.